Acute Myeloid Leukemia
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Choline Magnesium Trisalicylate and Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia [Phase 2]
Phase 2 trial updating the use of Choline Magnesium Trisalicylate in combination chemotherapy for various adult acute myeloid leukemia subty…
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer
This Clinical Trial Update describes a study collecting and storing malignant and related samples from young cancer patients; the trial stat…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Adoptive Transfer of Haplo-identical DLI for AML and MDS [Phase 1, Phase 2]
Clinical trial update for adoptive transfer of haplo-identical donor lymphocyte infusion in AML and MDS, completed with posted results in 20…
-
CLINICAL_TRIALS trial_result · 2018-07-05Clinical Trial Update: Ultra-Low Dose IL-2 Therapy as GVHD Prophylaxis in Haploidentical Allogeneic Stem Cell Transplantation [Phase 1]
Phase 1 trial update reporting completion of a study evaluating ultra-low-dose interleukin-2 as graft-versus-host disease prophylaxis in hap…
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: E7070, Idarubicin and Cytarabine in Relapsed AML and High-Risk Myelodysplastic Syndromes [Phase 2]
Phase 2 clinical trial evaluating E7070 in combination with idarubicin and cytarabine for relapsed acute myeloid leukemia and high-risk myel…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-03Clinical Trial Update: CPI-613, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 trial evaluating CPI-613 (devimistat) in combination with cytarabine and mitoxantrone hydrochloride for relapsed or refractory acute…
-
CLINICAL_TRIALS trial_result · 2018-07-02Clinical Trial Update: Decitabine and Plerixafor in Elderly Acute Myeloid Leukemia (AML) [Phase 1]
Phase 1 trial update of decitabine in combination with plerixafor in elderly patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2018-06-28Clinical Trial Update: Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes [Phase 1]
A Phase 1 trial update exploring dose escalation of cladribine in conditioning regimens before allogeneic stem cell transplantation for refr…
-
CLINICAL_TRIALS trial_result · 2018-06-27Clinical Trial Update: Pilot Study of Feasibility of Outpatient Daily High Dose Cytarabine as Consolidation Therapy for Older Patients With Acute Myeloid Leukemia (AML) [NA]
This completed pilot study assesses the feasibility of outpatient daily high-dose cytarabine as consolidation therapy for older adults with …
-
CLINICAL_TRIALS trial_result · 2018-06-15Clinical Trial Update: Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML [Phase 2]
Phase 2 trial evaluating pacritinib with decitabine or cytarabine in older patients with acute myeloid leukemia was terminated; results were…
-
CLINICAL_TRIALS trial_result · 2018-06-12Clinical Trial Update: Standard Idarubicin and Cytarabine for the Treatment of Acute Myeloid Leukemia (AML) [Phase 2]
Phase 2 clinical trial update evaluating standard idarubicin and cytarabine for acute myeloid leukemia has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation
The National Cancer Institute-sponsored clinical trial assessing relapse in malignant blood cancers after allogeneic hematopoietic stem cell…
-
CLINICAL_TRIALS trial_result · 2018-06-04Clinical Trial Update: Dose Escalation of OXi4503 as Single Agent and Combination With Cytarabine w/Subsequent Ph 2 Cohorts for AML and MDS [Phase 1, Phase 2]
Dose-escalation study of OXi4503 as a single agent and in combination with cytarabine, with subsequent Phase 2 cohorts planned for acute mye…
-
CLINICAL_TRIALS trial_result · 2018-06-01Clinical Trial Update: Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands [Phase 1]
Phase 1 safety study of CYAD-01, CAR T cells targeting NKG2D-ligands, completed; evaluated in acute myeloid leukemia, myelodysplastic syndro…
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Omacetaxine and Low Dose Cytarabine in Older Patients With Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) [Phase 2]
Phase 2 trial of omacetaxine with low-dose cytarabine in older patients with acute myeloid leukemia and high-risk myelodysplastic syndrome h…
-
CLINICAL_TRIALS trial_result · 2018-05-30Clinical Trial Update: Reduced Intensity Regimen vs Myeloablative Regimen for Myeloid Leukemia or Myelodysplastic Syndrome (BMT CTN 0901) [Phase 3]
Phase 3 trial comparing reduced intensity conditioning to myeloablative conditioning for acute myeloid leukemia and myelodysplastic syndrome…
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Liposomal Cytarabine-Daunorubicin CPX-351 in Treating Patients With Untreated Myelodysplastic Syndrome or Acute Myeloid Leukemia [NA]
ClinicalTrials.gov update on a completed trial evaluating CPX-351 (liposomal cytarabine-daunorubicin) for untreated myelodysplastic syndrome…
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: A Study To Evaluate PF-04449913 With Chemotherapy In Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Phase 2]
Phase 2 trial updating the evaluation of PF-04449913 in combination with chemotherapy for acute myeloid leukemia, with completed status and …
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia [Phase 2]
Phase 2 clinical trial evaluating Treo/Flu/TBI with donor stem cell transplant for myelodysplastic syndrome or acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: A Study of the Safety and Pharmacokinetics of RO6839921, An MDM2 Antagonist, in Patients With Advanced Cancers, Including Acute Myeloid Leukemia. [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of RO6839921 (idasanutlin), an MDM2 antagonist, in patients with advanced cancers includ…
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Ibrutinib, Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia [Phase 1]
Phase 1 trial evaluating a combination of ibrutinib, idarubicin, and cytarabine in adults with relapsed or refractory acute myeloid leukemia…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: A Phase 2 Trial of MLN8237 in Adult Participants With Acute Myelogenous Leukemia and High-Grade Myelodysplastic Syndrome [Phase 2]
A Phase 2 clinical trial update on MLN8237 (alisertib) in adults with acute myeloid leukemia and high-grade myelodysplastic syndrome; the st…
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: A Safety Study of SGN-CD33A in Combination With Standard-of-care in Patients With AML [Phase 1]
A completed Phase 1 safety study evaluating SGN-CD33A in combination with standard-of-care in patients with acute myeloid leukemia.
-
CLINICAL_TRIALS trial_result · 2018-04-27Clinical Trial Update: Pilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger Patients [Phase 2]
Phase 2 pilot study assessing efficacy and tolerability of a fish oil emulsion combined with daunorubicin and cytarabine in younger patients…
-
CLINICAL_TRIALS trial_result · 2018-04-23Clinical Trial Update: Respiratory Viral Infections During Acute Myeloid Leukemia (AML)Chemotherapy Related Aplasia [Phase 4]
A Phase 4 clinical trial evaluating respiratory viral infections during chemotherapy-induced aplasia in patients with acute myeloid leukemia…